Business

Novartis Sandoz unit completes Fougera purchase

By The Associated Press
Published July 23, 2012 12:44pm ET
Add Washington Examiner on Google

Swiss drugmaker Novartis AG’s Sandoz division has completed its $1.53 billion purchase of dermatology drug maker Fougera Pharmaceuticals.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.